Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.01
- Piotroski Score 3.00
- Grade Equal-Weight
- Symbol (EXAI)
- Company Exscientia plc
- Price $5.12
- Changes Percentage (1.19%)
- Change $0.06
- Day Low $5.06
- Day High $5.27
- Year High $7.91
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $5.00
- High Stock Price Target $5.00
- Low Stock Price Target $5.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.33
- Trailing P/E Ratio -4.05
- Forward P/E Ratio -4.05
- P/E Growth -4.05
- Net Income $-181,439,576
Income Statement
Quarterly
Annual
Latest News of EXAI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Exscientia Plc (EXAI): A Penny Stock That Will Make You a Millionaire
A list of promising penny stocks includes Exscientia Plc (NASDAQ:EXAI), an AI-driven pharma-tech company with potential in cancer treatment. With six hedge funds holding stakes, it ranks 9th....
By Yahoo! Finance | 2 weeks ago -
Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Despite some concerns about Exscientia's increasing cash burn and dropping revenue, the company seems to have a promising cash runway. Shareholders may face dilution if more cash is needed for operati...
By Yahoo! Finance | 2 months ago
